Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
11
11 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- PovorcitinibINCB054707, INCB54707Phase 312 trials
Incyte · Hidradenitis Suppurativa (HS), NonSegmental Vitiligo, Prurigo Nodularis
- INCB123667Phase 33 trials
Incyte · Ovarian Cancer
- INCA33890Phase 32 trials
Incyte · CRC (Colorectal Cancer)
- INCA033989Phase 31 trial
Incyte · Essential Thrombocythemia
- INCB161734Phase 31 trial
Incyte · Solid Tumors
- INCAGN02385Phase 23 trials
Incyte · Melanoma, Endometrial Cancer, Head and Neck Cancer
- INCAGN02390Phase 23 trials
Incyte · Melanoma, Endometrial Cancer, Head and Neck Cancer
- itacitinibINCB039110Phase 22 trials
Incyte · B-Cell Malignancies, Lung Cancer
- parsaclisibINCB050465Phase 22 trials
Incyte · Non Hodgkins Lymphoma, Diffuse Large B-cell Lymphoma, B-Cell Malignancies
- epacadostatPhase 21 trial
Incyte · Endometrial Cancer
- INCA000585Phase 21 trial
Incyte · Immune Thrombocytopenia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.